cycloguanil has been researched along with folic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christopherson, RI; Rieckmann, KH; Seymour, KK; Yeo, AE | 1 |
Reynolds, MG; Roos, DS | 1 |
Diriye, A; Kiara, S; Kokwaro, G; Masseno, V; Mwai, L; Nduati, E; Nzila, A; Ommeh, S | 1 |
Andrews, KT; Antonova-Koch, Y; Burrows, JN; Chopra, P; Clarke, M; Fidock, DA; Fisher, GM; Hutt, OE; Jarvis, KE; Meister, S; Riches, AG; Ryan, JH; Skinner-Adams, TS; von Itzstein, M; Wilson, T; Winzeler, EA | 1 |
4 other study(ies) available for cycloguanil and folic acid
Article | Year |
---|---|
Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
Topics: Animals; Antimalarials; Atovaquone; Drug Interactions; Folic Acid; Humans; Leucovorin; Naphthoquinones; Plasmodium falciparum; Proguanil; Purine Nucleotides; Pyrimethamine; Pyrimidine Nucleotides; Triazines | 1997 |
A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
Topics: Alleles; Animals; Binding Sites; Drug Resistance; Escherichia coli; Folic Acid; Folic Acid Antagonists; Genetic Complementation Test; Kinetics; Models, Genetic; Models, Molecular; Mutagenesis, Site-Directed; NAD; Plasmodium falciparum; Proguanil; Pyrimethamine; Recombinant Proteins; Tetrahydrofolate Dehydrogenase; Toxoplasma; Triazines | 1998 |
Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.
Topics: Aminopterin; Animals; Antimalarials; Antineoplastic Agents; Folic Acid; Folic Acid Antagonists; Inhibitory Concentration 50; Leucovorin; Methotrexate; Molecular Structure; Plasmodium falciparum; Proguanil; Pyrimethamine; Tetrahydrofolates; Triazines; Trimetrexate | 2008 |
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Cyclization; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Drug Combinations; Electron Transport Complex III; Enzyme Inhibitors; Erythrocytes; Folic Acid; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium berghei; Plasmodium falciparum; Proguanil; Sporozoites; Terpenes; Triazines | 2019 |